Apostle is a provider of technologies and services for public health and life sciences. Our innovations feature Apostle MagTouch Nucleic Acids Isolation Automation System, Apostle MiniMax cfDNA technologies (see Science, New Products), and others (catalog).

Our response and solution to help our community fight COVID-19 together: High Quality*, Lower Cost**, Faster #, Safer ##, Apostle COVID-19 Viral RNA Isolation Automation System (brochure), supported by a strong, ample, and stable global supply chain.

30,000+ samples processed daily. Clinically validated.

* Equal or better results compared with other brands. ** Guaranteed 30% - 50% less cost than other brands. # Run time is approximately 40 minutes per 96 samples. Approximately 2,500 samples per unit per 24 hours. ## Integrated with a UV light for unit interior disinfection.


Apostle Inc’s MiniEnrich Technology is Published at Royal Society of Chemistry’s Analyst
Apostle Inc is pleased to announce that the company’s original technology, termed the Apostle MiniEnrich Technology, is published at Royal Society of Chemistry’s Analyst on Sept 7, 2020, vol 145, issue 17, pp 5733-5739, and is selected as the inside front cover story. read more
Apostle Inc Appoints Charles (Buck) Strom to Board of Advisors
Apostle Inc is pleased to announce the appointment of Charles (Buck) Strom, MD, PhD, FAAP, FACMG, HCLD, as a new member to its Board of Advisors. read more
Apostle Inc to Present at the 5th Annual Liquid Biopsy Summit
Apostle Inc is pleased to announce that the company is going to present at the 5th Liquid Biopsy Summit, to take place in Seattle, WA on June 15-17, 2020. David Ge, CEO of Apostle, will discuss Apostle MiniEnrich, a novel method for enrichment of short DNA fragments for NIPT and oncology applications. read more